Skip to main content
Clinical Trials/JPRN-jRCT1080222457
JPRN-jRCT1080222457UnknownUnknown

Freeze-dried live attenuated measles and rubella combined vaccine Takeda Specified drug-use survey of vaccinees after the second vaccination

TAKEDA PHARMACEUTICAL COMPANY LTD.0 sites3,000 target enrollmentStarted: April 9, 2014Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Sponsor
Enrollment
3,000

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Vaccinees who meet both of the following conditions [1] and [2]:
  • [1] Vaccinees who have a prior history of receiving measles and/or rubella vaccination and who received freeze-dried live attenuated measles and rubella combined vaccine Takeda as the second vaccination
  • [2] Vaccinees whose guardians are able to participate in a questionnaire survey on the health status of vaccinees after vaccination with freeze-dried live attenuated measles and rubella combined vaccine Takeda

Exclusion Criteria

  • Not provided

Investigators

Sponsor
TAKEDA PHARMACEUTICAL COMPANY LTD.

Similar Trials